ResearcherUniversity of LiverpoolNo recent work listed

N. Bird

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4997-1073; OpenAlex author ID A5067370103. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based… Co-author DOI 10.1002/bjs.10482 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert Peter Jones · 1 shared paper, 2017 · strength 0.06
- Paper Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcino… DOI 10.1002/bjs.10482 ↗
Paula Ghaneh · 1 shared paper, 2017 · strength 0.06
- Paper Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcino… DOI 10.1002/bjs.10482 ↗
Daniel H. Palmer · 1 shared paper, 2017 · strength 0.06
- Paper Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcino… DOI 10.1002/bjs.10482 ↗
John P. Neoptolemos · 1 shared paper, 2017 · strength 0.06
- Paper Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcino… DOI 10.1002/bjs.10482 ↗
William Greenhalf · 1 shared paper, 2017 · strength 0.06
- Paper Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcino… DOI 10.1002/bjs.10482 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.